Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

LAUNCHED: Metropolitan Life Global Funding I €500m 7yr FA-Backed; MS+90bp

IGC European Market: Deal Flow - General

Issuer

Term

Maturity

Size

Ranking

Type

IPT

Spread Set

Metropolitan Life Global Funding I

7yr

27-May-33

€500m

FA-Backed

Fixed

MS+105/110

MS+90


Launched: 7yr: €500m @ MS+90bp - Orderbook in excess of €825m
IPTs: 7yr: MS+105/110bp


  • Issuer: Metropolitan Life Global Funding I
  • LEI Number: 635400MMSOCXNNNZDZ82
  • Funding Agreement Provider: Metropolitan Life Insurance Company
  • Expected Security Ratings: Aa3/AA-/AA- (Moody's/S&P/Fitch)
  • Format: Funding Agreement-Backed notes, Reg S Cat 3 (Registered)
  • Size: €500m
  • Settlement: 27-May-26 (T+5)
  • Maturity: 27-May-33
  • Coupon: Fixed-Rate, Annual (Act/Act)
  • Benchmark Security: DBR 2.300% 15-Feb-33
  • Docs: U.S.$40,000,000,000 Global Note Issuance Program Offering Circular, dated 05-Dec-25, as supplemented by the First Offering Circular Supplement, dated 11-Mar-26, and the Second Offering Circular Supplement, dated 13-May-26
  • Target Market: MiFID II/UK MiFIR Eligible counterparties and professional clients only (all distribution channels). No sales to EEA or UK retail. No KID will be prepared.
  • Expected Listing: Euronext Dublin
  • Advertisement: The Offering Circular is available at https://live.euronext.com/en/product/bonds-detail/p525%7C24523/documents
  • Governing Law: New York Law
  • Denom: €100k x €1k
  • UoP: To purchase relevant Funding Agreements from Metropolitan Life Insurance Company
  • Bookrunners: BNP Paribas, Deutsche Bank(B&D), Goldman Sachs International, J.P. Morgan
  • ISIN: XS3386672565
  • Timing: Today’s Business
  • Books Subject: At 12:45 UKT
  • Sales into Canada: Yes, exemption
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.